AI Image
FDA recalls thousands of blood pressure bottles after it failed quality tests
WGAL • • health
Key Points:
- The U.S. Food and Drug Administration (FDA) has issued a nationwide recall of certain blood pressure medications produced by Macleods Pharma USA due to quality concerns.
- The recall, initiated on October 7, 2026, and classified as Class II on October 26, 2026, involves Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets, which may cause temporary or reversible health issues.
- Specifically, 3,528 bottles of 30-count (lot 12251163A) and 216 bottles of 90-count (lot 12251163B), all expiring on May 31, 2027, are affected by the recall.
- The FDA enforcement report indicated the medication failed quality standards because the pills did not dissolve properly during testing, prompting the recall.
